Shivom is powering the next era of genomics through blockchain technology – by protecting identity, personalizing healthcare, transforming lives. Our blockchain based genomics and healthcare platform will allow the transition to value-based precision healthcare. Our focus is on the transformational convergence of OMICS technologies with blockchain, artificial intelligence and machine learning to enable secure and personalized medicine with global scalability.
About Project Shivom
SHIVOM is building the largest genomic and health data hub around the globe by combining blockchain, genomic DNA sequencing, artificial intelligence and cryptography to power secure and personalized medicine.
Everybody will be able to get their genome sequenced and securely stored, and our ecosystem will offer an open web-marketplace for providers to add their apps and services alongside advanced data analytics. The SHIVOM platform works on principles of collaboration and integrity, allowing people to own, manage and monetize their genomics and health data. As we build this global healthcare ecosystem, we will reach even underserved and low-income countries where such services have not been previously available.
Our solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.
We have partnered with the top developers and healthcare organizations, and technology companies and big pharma are already lining up to take advantage of our unique genomics and healthcare approach. As Shivom scales up and goes global, we have many more partnerships already in development.
The platform is truly pioneering in the way it utilizes blockchain technology, to protect, secure and monetize the donor’s DNA data to drive precision medicine and healthcare forward.
Shivom offers the first ever integrated solution for patients and genome data donors where everybody will be able to have their genome sequenced and securely stored. This ecosystem will provide an open web-marketplace for other providers such as pharmaceuticals, research organizations, governments, patient-support groups and insurance companies to add their apps and services, alongside genomic data analytics and personalized medicine.
We envision a future where genomic data becomes ubiquitous, with its insights for enhancing healthcare securely available and accessible to all. Shivom is pioneering the omics ecosystem to make this vision a reality by offering a rst-of-its-kind investment proposition in the rapidly growing market for personalized medicine, powered by state-of-the-art blockchain technology.
We will additionally build a state-of-the art and not-for-pro t drug discovery and precision medicine organization. Shivom researchers will use data-driven tools and techniques, particularly machine learning methods that underpin artificial intelligence, which will offer promise in improving healthcare systems and services around the globe.
Blockchain technology is our tech partner of choice because it is able to address trust issues, including patient consent, data ownership, data integrity, and authentication. Blockchain can also manage complex data rights and allow ne- grained access using smart contracts.
To make the direct-to-consumer business more open, fair, and beneficial to all users, the Shivom platform uses blockchain technology to create a disruptive genomics ecosystem. It ensures data is owned by the data donors themselves. It ensures a transparent and secure bridge to organizations interested in using that data.
- Genome data donors own their data and access rights
- Donors gain rewards for sharing their genomic data on the blockchain by selling access rights directly to third party institutions such as pharmaceutical companies
- Pharmaceutical companies use the Shivom platform to re ne drug development
- Shivom users have full and ne-grained control of who can access the data even after a third party institution has had access to it
- Patients get personalized health, well-being, and lifestyle information
- A dynamic ecosystem is created and continuously re ned in which the community can identify and remove potential health roadblocks before they become serious
TOKEN SALE INFORMATION:
Token Sale: April – May (no exact dates)
Token type: ERC20
ICO Token Price: 1 OmiX = 0.0568 USD (0.00014 ETH)
Fundraising Goal: 29,800,000 USD (75,000 ETH)
Total Tokens: 3,000,000,000
Available for Token Sale: 33%
Know Your Customer (KYC): Yes
Сan’t participate: USA
Token Issue: In 2 weeks after public token sale
Accepts: ETH, BTC, USD